These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32039688)

  • 1. Application of Nanomaterials in the Treatment and Diagnosis of Ophthalmology Diseases.
    Liu N; Wu Q; Liu Y; Li J; Ji P; Fu G
    Curr Stem Cell Res Ther; 2021; 16(1):95-103. PubMed ID: 32039688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterial-based ophthalmic drug delivery.
    Xie G; Lin S; Wu F; Liu J
    Adv Drug Deliv Rev; 2023 Sep; 200():115004. PubMed ID: 37433372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Using nanotechnology and nanomaterials in ophthalmology].
    Zhdanova OV; Chekman IS; Rykov SO
    Lik Sprava; 2010; (5-6):21-30. PubMed ID: 21488365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in drug formulation design and delivery of medicinal substances used in ophthalmology.
    Wróblewska KB; Jadach B; Muszalska-Kolos I
    Int J Pharm; 2021 Sep; 607():121012. PubMed ID: 34400274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases.
    Wu Y; Li X; Fu X; Huang X; Zhang S; Zhao N; Ma X; Saiding Q; Yang M; Tao W; Zhou X; Huang J
    Adv Sci (Weinh); 2024 Aug; 11(32):e2403399. PubMed ID: 39031809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
    Durgun ME; Güngör S; Özsoy Y
    J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances of nanomaterials applied in ophthalmic treatment].
    Chen SY; Fu QL; Yao K
    Zhonghua Yan Ke Za Zhi; 2022 Oct; 58(10):831-838. PubMed ID: 36220659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon quantum dots for the diagnosis and treatment of ophthalmic diseases.
    Zhang X; Yang L; Wang F; Su Y
    Hum Cell; 2024 Sep; 37(5):1336-1346. PubMed ID: 39093514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogels in ophthalmic applications.
    Kirchhof S; Goepferich AM; Brandl FP
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems.
    Peters MCC; Santos Neto ED; Monteiro LM; Yukuyama MN; Machado MGM; de Oliveira IF; Zanin MHA; Löbenberg R; Bou-Chacra N
    J Drug Target; 2020 Mar; 28(3):259-270. PubMed ID: 31491352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
    Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
    Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthatome™: an integrated knowledgebase of ophthalmic diseases for translating vision research into the clinic.
    Raj P; Tejwani S; Sudha D; Muthu Narayanan B; Thangapandi C; Das S; Somasekar J; Mangalapudi S; Kumar D; Pindipappanahalli N; Shetty R; Ghosh A; Kumaramanickavel G; Chaudhuri A; Soumittra N
    BMC Ophthalmol; 2020 Nov; 20(1):442. PubMed ID: 33172432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics.
    Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
    Expert Opin Drug Deliv; 2019 Apr; 16(4):397-413. PubMed ID: 30889977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-ophthalmology: Applications and considerations.
    Kamaleddin MA
    Nanomedicine; 2017 May; 13(4):1459-1472. PubMed ID: 28232288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and toxicity of nanomaterials for ocular drug delivery applications.
    Mehra NK; Cai D; Kuo L; Hein T; Palakurthi S
    Nanotoxicology; 2016 Sep; 10(7):836-60. PubMed ID: 27027670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.